These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27613867)

  • 21. Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity.
    Shen X; Yang L; Yan S; Zheng H; Liang L; Cai X; Liao M
    Mol Cell Endocrinol; 2015 Sep; 412():1-11. PubMed ID: 25986658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cells.
    Saitoh Y; Chun-ping C; Noma K; Ueno H; Mizuta M; Nakazato M
    Diabetes Obes Metab; 2008 Jul; 10(7):564-73. PubMed ID: 17593232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states.
    Zhang D; So WY; Wang Y; Wu SY; Cheng Q; Leung PS
    Clin Sci (Lond); 2017 Feb; 131(3):247-260. PubMed ID: 27980130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin.
    Yin H; Park SY; Wang XJ; Misawa R; Grossman EJ; Tao J; Zhong R; Witkowski P; Bell GI; Chong AS
    PLoS One; 2013; 8(6):e65777. PubMed ID: 23762423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice.
    Akiyama M; Hatanaka M; Ohta Y; Ueda K; Yanai A; Uehara Y; Tanabe K; Tsuru M; Miyazaki M; Saeki S; Saito T; Shinoda K; Oka Y; Tanizawa Y
    Diabetologia; 2009 Apr; 52(4):653-63. PubMed ID: 19190890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients.
    Klotz L; Schmidt M; Giese T; Sastre M; Knolle P; Klockgether T; Heneka MT
    J Immunol; 2005 Oct; 175(8):4948-55. PubMed ID: 16210596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone reduces ER stress in the liver: direct monitoring of in vivo ER stress using ER stress-activated indicator transgenic mice.
    Yoshiuchi K; Kaneto H; Matsuoka TA; Kasami R; Kohno K; Iwawaki T; Nakatani Y; Yamasaki Y; Shimomura I; Matsuhisa M
    Endocr J; 2009; 56(9):1103-11. PubMed ID: 19789420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phlda3 regulates beta cell survival during stress.
    Bensellam M; Chan JY; Lee K; Joglekar MV; Hardikar AA; Loudovaris T; Thomas HE; Jonas JC; Laybutt DR
    Sci Rep; 2019 Sep; 9(1):12827. PubMed ID: 31492921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SLC3A2 is a novel endoplasmic reticulum stress-related signaling protein that regulates the unfolded protein response and apoptosis.
    Liu C; Li X; Li C; Zhang Z; Gao X; Jia Z; Chen H; Jia Q; Zhao X; Liu J; Liu B; Xu Z; Tian Y; He K
    PLoS One; 2018; 13(12):e0208993. PubMed ID: 30592731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway.
    Lin CY; Gurlo T; Haataja L; Hsueh WA; Butler PC
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6678-86. PubMed ID: 16204373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of DSP-8658, a novel selective peroxisome proliferator-activated receptors a/γ modulator, on adipogenesis and glucose metabolism in diabetic obese mice.
    Goto T; Nakayama R; Yamanaka M; Takata M; Takazawa T; Watanabe K; Maruta K; Nagata R; Nagamine J; Tsuchida A; Kato H
    Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):492-9. PubMed ID: 26011171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPAR-gamma overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells.
    Nakamichi Y; Kikuta T; Ito E; Ohara-Imaizumi M; Nishiwaki C; Ishida H; Nagamatsu S
    Biochem Biophys Res Commun; 2003 Jul; 306(4):832-6. PubMed ID: 12821117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of muscular dystrophy, exercise and blocking activin receptor IIB ligands on the unfolded protein response and oxidative stress.
    Hulmi JJ; Hentilä J; DeRuisseau KC; Oliveira BM; Papaioannou KG; Autio R; Kujala UM; Ritvos O; Kainulainen H; Korkmaz A; Atalay M
    Free Radic Biol Med; 2016 Oct; 99():308-322. PubMed ID: 27554968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations.
    Lamontagne J; Pepin E; Peyot ML; Joly E; Ruderman NB; Poitout V; Madiraju SR; Nolan CJ; Prentki M
    Endocrinology; 2009 Aug; 150(8):3465-74. PubMed ID: 19406947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis.
    Larsen PJ; Jensen PB; Sørensen RV; Larsen LK; Vrang N; Wulff EM; Wassermann K
    Diabetes; 2003 Sep; 52(9):2249-59. PubMed ID: 12941763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus.
    Defronzo RA; Mehta RJ; Schnure JJ
    Hosp Pract (1995); 2013 Apr; 41(2):132-47. PubMed ID: 23680744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of peroxisome proliferator-activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus.
    Gupta D; Kono T; Evans-Molina C
    Diabetes Obes Metab; 2010 Dec; 12(12):1036-47. PubMed ID: 20977574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.
    Kanatani Y; Usui I; Ishizuka K; Bukhari A; Fujisaka S; Urakaze M; Haruta T; Kishimoto T; Naka T; Kobayashi M
    Diabetes; 2007 Mar; 56(3):795-803. PubMed ID: 17327450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
    Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
    Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells.
    Guo B; Koya D; Isono M; Sugimoto T; Kashiwagi A; Haneda M
    Diabetes; 2004 Jan; 53(1):200-8. PubMed ID: 14693716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.